Researching ME/CFS: priority area
UKRI funding supports research into ME/CFS, prioritizing studies on biological mechanisms, diagnostics, treatments, and multidisciplinary collaboration with patient involvement.
Funder: UK Research and Innovation
Due Dates: Rolling (No closing date)
Funding Amounts: Usually up to 80% of full economic cost; award size and duration depend on the underlying MRC scheme selected.
Summary: Supports research into ME/CFS, prioritizing biological mechanisms, diagnostics, treatments, and multidisciplinary collaboration with patient involvement.
Key Information: Submit through any open MRC funding scheme; ME/CFS proposals receive prioritization if ranked equally with others.
Description
This funding opportunity supports research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through any of the Medical Research Council’s (MRC) grant or fellowship schemes. The initiative specifically encourages high-quality applications addressing scientific priorities such as the biological mechanisms of post-exertional malaise, drug repurposing, diagnostics, immune system involvement, disease stratification, post-infection evaluation, neurological symptoms, genetic susceptibility, disease severity, and mitochondrial or oxygenation dysfunction.
Applicants are encouraged to form multidisciplinary teams, involve people with ME/CFS in research design and execution, and collaborate with patient groups. Proposals that align with the research priorities identified by the ME/CFS Priority Setting Partnership will be prioritized for funding if they attain the same ranking as other submissions. Resources such as the Researcher Toolkit and the PRIME initiative are available to support application quality and patient/public involvement.
